LEUPROLIDE ACETATE DEPOT (LEUPROLIDE ACETATE)
LEUPROLIDE ACETATE DEPOT (LEUPROLIDE ACETATE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: LEUPROLIDE ACETATE DEPOT; Generic name: LEUPROLIDE ACETATE; Manufacturer: CIPLA USA INC..
| Brand name | LEUPROLIDE ACETATE DEPOT |
|---|---|
| Generic name | LEUPROLIDE ACETATE |
| Manufacturer | CIPLA USA INC. |
| Used for | 1. INDICATIONS AND USAGE LEUPROLIDE ACETATE FOR DEPOT SUSPENSION 22.5 mg for 3-month administration (leuprolide acetate) is indicated for treatment of advanced prostate cancer. LEUPROLIDE ACETATE FOR DEPOT SUSPENSION is a gonadotropin-releasing hormone (GnRH) agonist indicated for: Treatment of advanced prostate cancer. ( 1 ) |
| Dosage | 2. DOSAGE AND ADMINISTRATION Due to different release characteristics, the dosage strengths are not additive and must be selected based upon the desired dosing schedule ( 2 ). LEUPROLIDE ACETATE FOR DEPOT SUSPENSION 22.5 mg for 3 months administration, given as a single intramuscular injection every 12 weeks. ( 2.1 ) 2.1 LEUPROLIDE ACETATE FOR DEPOT SUSPENSION 22.5 mg for 3-Month Administration LEUPROLIDE ACETATE FOR DEPOT SUSPENSION must be administered under the supervision of a physician. In |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1563a30b-66e0-445d-ba3e-1ccd5218133f |